DAFTAR PUSTAKA Hubungan Kadar Ldl-Kolesterol Pada Penderita Diabetes Melitus Tipe 2 Dengan Kejadian Stroke Iskemik Di RSUD Dr. Moewardi.
DAFTAR PUSTAKA
Adam, J.M.F., Josten, D. 2008. Isolated Post-challenge Hyperglycemia: Concept
and Clinical Significance. Acta Med Indones-Indones J Intern Med. 40:171.
Adam, J.M.F., Tarigan, N.P. 2004. Comparison of The World Health
Organization (WHO) Two-Step Strategy and OGTT for Diabetes Mellitus
Screening. Acta Med Indones-Indones J Intern Med. 36:3.
Adams, H. 2009. Secondary Prevention of Atherothrombotic Events After
Ischemic Stroke. Mayo Clin Proc. 84:45.
Air, E.L., Kissela, B.M. 2007. Diabetes, the Metabolic Syndrome, and Ischemic
Stroke Epidemiology and possible mechanisms. Diabetes Care. 30:314.
Almatsier, S. 2010. Prinsip Dasar Ilmu Gizi. Jakarta: Penerbit Gramedia pp. 6368.
Almdal, T., Scharling, H., Jensen, J.S., Vestergaard, H. 2004. The Independent
Effect of Type 2 Diabetes Mellitus on Ischemic Heart Disease, Stroke, and
Death. Arch Intern Med. 164:1422-1426.
American Heart Association 2003. Heart Disease and Stroke Statistics-2004
Update Dallas Texas
Anonim1. 2009. Prevent Diabetes Problems Keep Heart and Blood Vessels
Healthy. www.WHO.int (10 April 2012).
Arfianti. 2008. Stres Oksidatif dan Penghantaran Sinyal Insulin: Patogenesis
Resistensi Insulin. Jurnal Kesehatan Indonesia . 2:88-94.
Aronson, D., Rayfield, E.J. 2002. How Hyperglycemia Promotes Atherosclerosis:
Molecular Mechanisms. Cardiovasc Diabetol. 1:1.
Banerjee, C., Moon, Y.P., Paik, M.C., Rundek, T., Mora-McLaughlin, C., Vieira,
J.R., Sacco, R.L., Elkind, M.S. 2012. Duration of Diabetes and Risk of
Ischemic Stroke: The Northern Manhattan Study. Stroke AHA. 5:43
Beigi, F.I. 2012. Glycemic Management of Type 2 Diabetes Mellitus. The New
England Journal Medicine. 366:1320.
Beckman, J.A., Creager, M.A., Libby, Peter., 2002. Diabetes and Atherosclerosis
Epidemiology, Pathophysiology, and Management. American Medical
Association. 287:2570-2581.
48
49
Beckman, J.A., 2004. Pathophysiology of Vascular Dysfunction in Diabetes.
Cardilogy Rounds. Vol:8.
Bitzur, R., Cohen, H., Kamari, Y., Shaish, A., Harats, D. 2009. Triglycerides and
HDL Cholesterol Stars or Second Leads in diabetes?. Diabetes Care. 32:1.
Botham, A.R., Mayes, P.A. 2009. Sintesis, Transpor dan Ekskresi Kolesterol,
dalam: Wulandari dkk edisi Indonesia. Murray, R.K., Granner, D.K.,
Rodwell, V.W. Biokimia harper. EGC, Mc Graw Hill. pp 239-248.
Bruno, A., Liebeskind, D., Raychev, Radoslav., Hao, Q. 2010. Diabetes Mellitus,
Acute Hyperglycemia, and Ischemic Stroke. Current Treatment Options in
Neurology. 12:493.
Bryer, M. 2012. 100 Tanya-Jawab Mengenai Diabetes. Jakarta:Indeks pp 5.
CDC. 2012. Number (in Millions) of Persons with Diabetes Aged 35 Years or
Older with Self-Reported Heart Disease or Stroke, United States , 1997–2010
www.CDC.gov (29 juni 2012)
Dahlan, M.S. 2010. Langkah-Langkah Membuat Proposal Penelitian Bidang
Kedokteran dan Kesehatan. Jakarta:Sagung Seto pp 80-98.
Dahlan, M.S. 2011. Statistik untuk Kedokteran dan Kesehatan. Jakarta:Salemba
Medika pp 62&209.
Davey, P. 2008. At a Glance Medicine. Jakarta:Erlangga pp 268-289.
Davis, T.M.E., Millns, H., Stratton, I.M., Holman, R.R., Turner, R.C. 1999. Risk
Factor Stroke in Type 2 Diabetes Mellitus United Kingdom Prospective
Diabetes Study UKPDS 29. Arch Intern Med. 159:1101.
Defronzo, A.R. 2009. Insulin Resistance, Lipotoxicity, Type 2 Diabetes and
Atherosclerosis: The Missing Links. Diabetologia . 53:1270.
Fowler, M.J. 2008. Microvascular and Macrovascular
Diabetes. Clinical Diabetes. 26:79.
Goetz, C.G. 2007. Textbook of Clinical Neurology
Philadelphia:Saunders Elsevier pp 1020-1023.
Complications of
Third
Edition .
Gofir, A. 2009. Manajemen Stroke. Yogyakarta:Pustaka Cendekia. p 108.
Greenstein, B., Wood, D. 2006. At a Glance Sistem Endokrin . Jakarta:Erlangga
Medical Series pp 80-99.
50
Guyton, A.C. Hall, J.E. 2008. Buku Ajar Fisiologi Kedokteran Edisi 11.
Jakarta:EGC pp 882-1010.
Hardman, J.G., Limbird, L.E. 2008. Goodman & Gilman Dasar Terapi
Farmakologi Edisi 10 Vol. 1. Jakarta:EGC p 959.
Howard, B.V. 1987. Lipoprotein Metabolism in Diabetes Mellitus. Journal of
Lipid Research. 28:617.
Iskandar, J. 2011. Stroke Waspadai Ancamannya: Panduan Stroke Paling
Lengkap. Yogyakarta:Penerbit ANDI pp 141.
Katzung, G.B. 2002. Farmakologi Dasar dan Klinik Buku 2 Edisi 8. Jakarta:
Penerbit Salemba Medika p 441.
Kim, J.S., Sunwoo, N.I., Kim, J.S. 1989. Risk Factors of Ischemic Brain stroke in
Korean Diabetic Patient A Retrospective Study. Yonsei Medical Journal.
30:291.
Kothari, V., Stevens, R.J., Adler, A.I., Stratton, I.M., Manley, S.E., Neil, H.A.,
Holman, R.R. 2002. UKPDS 60 Risk of Stroke in Type 2 Diabetes Estimated
by the UK Prospective Diabetes Study Risk Engine. Journal of the American
Heart Assosiation. 33:1778.
Kumar, V., Cotran, R.S., Robbins, S.T. 2007. Buku Ajar Patologi Volume 2.
Edisi 7. Jakarta:EGC pp. 367-377.
Lim, J.H., Lee, Y.S., Chang, H.C., Moon, M.K., Song, J.Y. 2011. Association
between Dietary Patterns and Blood Lipid Profiles in Korean Adults with
Type 2 Diabetes. J Korean Med Sci. 26:1201-1208.
McCance, K.L., Hyuther S.E. 2006. Pathophysiology The Biologic Basic For
Disease In Adult and Children Fifth Edition . Philadelphia:Elsevier Mostly pp
565&700.
Mumpuni, Y., Wulandari, A. 2011. Cara Jitu Mengatasi Kolesterol: Cerdas
Mengatasi dan Mengendalikan Kolesterol. Jakarta:Penerbit Andi pp 44.
Nathan, D.M. 2002. Initial Management Of Glycemia In Type 2 Diabetes
Mellitus. The New England Journal Medicine. 347:1343-1344.
Neal, M.J. 2007. At a Glance Farmakologi Medis. Jakarta:Erlangga Medical
Series p 47.
51
Nesto, R.W. 2008. LDL Cholesterol Lowering in Type Diabetes: What Is the
Optimum Approach?. Clinical Diabetes. 26:9.
NHLBI 2002. National Institutes of Health, Detection, Evaluation and Treatment
of High Blood Cholesterol in Adults (Adults Treatment Panel III). pp 23-24.
Ni, Khan., L, Naz., Mustaq., Rukh., Hussain. 2009. Ischemic Stroke: Prevalence
of Modifiable Risk Factor in Male and Female Patient in Pakistan. Pak. J.
Pharm. Sci. 22:62.
Notoadmodjo, S. 2005. Metodologi Penelitian Kesehatan. Jakarta: Rineka Cipta.
Park, Adrian. 2010. Hyperlipidaemia. Medical Progress. 37:382.
PERKENI 2006. Konsesus Pengelolahan dan Pencegahan Diabetes Melitus Tipe
2 di Indonesia.
Price, S.A., Wilson, L.M. 2006. Patofisiologi Konsep Klinis Proses-Proses
Penyakit Volume 2. Edisi 6. Jakarta:EGC pp. 1113.
Rasyid, A., Soertidewi, Lyna. 2007. Unit Stroke Manajemen Stroke Secara
Komprehensif. Jakarta: Balai Penerbti FKUI. pp 26.
RISKESDAS. 2007. Riset Kesehatan Dasar (Riskesdas) Laporan Provinsi Jawa
Tengah. Jakarta:Badan Penelitian dan Perkembangan Kesehatan.
Romero, J.R., Morris, J., Pikula, A. 2008. Stroke Prevention: Modifying Risk
Factors. Ther Adv Cardiovasc Dis. 2:291.
Sander, D., Sander, K., Poppert, H. 2008. Review: Stroke in Type 2 diabetes.
Journal of Diabetes and Vaskular Disease. 8:224.
Semenkovich, C.F. 2006. Insulin Resistance and Atherosclerosis. The Journal of
Clinical Investigation. 116:1813.
Setiawan, B., Suhartono, E. 2005. Stres Oksidatif dan Peran Antioksidan pada
Diabetes Melitus. Majalah Kedokteran Indonesia. 55:87.
Shao-Hua, W. 2009. Dyslipidaemia Among Diabetic Patients with Ischemic
Stroke in a Chinese Hospital. Chinese Medical Journal. 122:2569.
Silbernagl, S., Lang, F. 2007. Teks & Atlas Berwarna Patofisiologi. Jakarta:EGC
pp 246-247.
52
Simonen, P.P., Gylling, H., Miettinen, T. 2002. Diabetes Contributes to
Cholesterol Metabolism Regardless of Obesity. Diabetes Care. 25:151.
Soegondo, S., Pradana, S., Subekti, I. 2009. Penatalaksanaan Diabetes Melitus
Terpadu. Jakarta:Balai Penerbit FKUI pp 17-29.
Tjay, H.T., Rahardja, K. 2007. Obat-Obat Penting Khasiat, Penggunaan dan
Efek-Efek Sampingnya Edisi Keenam. Jakarta: Elex Media Komputindo p
580.
Underwood, J.C.E. 2000. Patologi Umum dan Sistemik Edisi 2 Volume 2 .
Jakarta:EGC. p 331.
WHO 2003. World Health Report 2003 Shaping the Future.
Worp, B.V.D., Ginjn, J.V. 2007. Acute Ischemic Stroke. The New England
Journal Medicine. 375:573.
Adam, J.M.F., Josten, D. 2008. Isolated Post-challenge Hyperglycemia: Concept
and Clinical Significance. Acta Med Indones-Indones J Intern Med. 40:171.
Adam, J.M.F., Tarigan, N.P. 2004. Comparison of The World Health
Organization (WHO) Two-Step Strategy and OGTT for Diabetes Mellitus
Screening. Acta Med Indones-Indones J Intern Med. 36:3.
Adams, H. 2009. Secondary Prevention of Atherothrombotic Events After
Ischemic Stroke. Mayo Clin Proc. 84:45.
Air, E.L., Kissela, B.M. 2007. Diabetes, the Metabolic Syndrome, and Ischemic
Stroke Epidemiology and possible mechanisms. Diabetes Care. 30:314.
Almatsier, S. 2010. Prinsip Dasar Ilmu Gizi. Jakarta: Penerbit Gramedia pp. 6368.
Almdal, T., Scharling, H., Jensen, J.S., Vestergaard, H. 2004. The Independent
Effect of Type 2 Diabetes Mellitus on Ischemic Heart Disease, Stroke, and
Death. Arch Intern Med. 164:1422-1426.
American Heart Association 2003. Heart Disease and Stroke Statistics-2004
Update Dallas Texas
Anonim1. 2009. Prevent Diabetes Problems Keep Heart and Blood Vessels
Healthy. www.WHO.int (10 April 2012).
Arfianti. 2008. Stres Oksidatif dan Penghantaran Sinyal Insulin: Patogenesis
Resistensi Insulin. Jurnal Kesehatan Indonesia . 2:88-94.
Aronson, D., Rayfield, E.J. 2002. How Hyperglycemia Promotes Atherosclerosis:
Molecular Mechanisms. Cardiovasc Diabetol. 1:1.
Banerjee, C., Moon, Y.P., Paik, M.C., Rundek, T., Mora-McLaughlin, C., Vieira,
J.R., Sacco, R.L., Elkind, M.S. 2012. Duration of Diabetes and Risk of
Ischemic Stroke: The Northern Manhattan Study. Stroke AHA. 5:43
Beigi, F.I. 2012. Glycemic Management of Type 2 Diabetes Mellitus. The New
England Journal Medicine. 366:1320.
Beckman, J.A., Creager, M.A., Libby, Peter., 2002. Diabetes and Atherosclerosis
Epidemiology, Pathophysiology, and Management. American Medical
Association. 287:2570-2581.
48
49
Beckman, J.A., 2004. Pathophysiology of Vascular Dysfunction in Diabetes.
Cardilogy Rounds. Vol:8.
Bitzur, R., Cohen, H., Kamari, Y., Shaish, A., Harats, D. 2009. Triglycerides and
HDL Cholesterol Stars or Second Leads in diabetes?. Diabetes Care. 32:1.
Botham, A.R., Mayes, P.A. 2009. Sintesis, Transpor dan Ekskresi Kolesterol,
dalam: Wulandari dkk edisi Indonesia. Murray, R.K., Granner, D.K.,
Rodwell, V.W. Biokimia harper. EGC, Mc Graw Hill. pp 239-248.
Bruno, A., Liebeskind, D., Raychev, Radoslav., Hao, Q. 2010. Diabetes Mellitus,
Acute Hyperglycemia, and Ischemic Stroke. Current Treatment Options in
Neurology. 12:493.
Bryer, M. 2012. 100 Tanya-Jawab Mengenai Diabetes. Jakarta:Indeks pp 5.
CDC. 2012. Number (in Millions) of Persons with Diabetes Aged 35 Years or
Older with Self-Reported Heart Disease or Stroke, United States , 1997–2010
www.CDC.gov (29 juni 2012)
Dahlan, M.S. 2010. Langkah-Langkah Membuat Proposal Penelitian Bidang
Kedokteran dan Kesehatan. Jakarta:Sagung Seto pp 80-98.
Dahlan, M.S. 2011. Statistik untuk Kedokteran dan Kesehatan. Jakarta:Salemba
Medika pp 62&209.
Davey, P. 2008. At a Glance Medicine. Jakarta:Erlangga pp 268-289.
Davis, T.M.E., Millns, H., Stratton, I.M., Holman, R.R., Turner, R.C. 1999. Risk
Factor Stroke in Type 2 Diabetes Mellitus United Kingdom Prospective
Diabetes Study UKPDS 29. Arch Intern Med. 159:1101.
Defronzo, A.R. 2009. Insulin Resistance, Lipotoxicity, Type 2 Diabetes and
Atherosclerosis: The Missing Links. Diabetologia . 53:1270.
Fowler, M.J. 2008. Microvascular and Macrovascular
Diabetes. Clinical Diabetes. 26:79.
Goetz, C.G. 2007. Textbook of Clinical Neurology
Philadelphia:Saunders Elsevier pp 1020-1023.
Complications of
Third
Edition .
Gofir, A. 2009. Manajemen Stroke. Yogyakarta:Pustaka Cendekia. p 108.
Greenstein, B., Wood, D. 2006. At a Glance Sistem Endokrin . Jakarta:Erlangga
Medical Series pp 80-99.
50
Guyton, A.C. Hall, J.E. 2008. Buku Ajar Fisiologi Kedokteran Edisi 11.
Jakarta:EGC pp 882-1010.
Hardman, J.G., Limbird, L.E. 2008. Goodman & Gilman Dasar Terapi
Farmakologi Edisi 10 Vol. 1. Jakarta:EGC p 959.
Howard, B.V. 1987. Lipoprotein Metabolism in Diabetes Mellitus. Journal of
Lipid Research. 28:617.
Iskandar, J. 2011. Stroke Waspadai Ancamannya: Panduan Stroke Paling
Lengkap. Yogyakarta:Penerbit ANDI pp 141.
Katzung, G.B. 2002. Farmakologi Dasar dan Klinik Buku 2 Edisi 8. Jakarta:
Penerbit Salemba Medika p 441.
Kim, J.S., Sunwoo, N.I., Kim, J.S. 1989. Risk Factors of Ischemic Brain stroke in
Korean Diabetic Patient A Retrospective Study. Yonsei Medical Journal.
30:291.
Kothari, V., Stevens, R.J., Adler, A.I., Stratton, I.M., Manley, S.E., Neil, H.A.,
Holman, R.R. 2002. UKPDS 60 Risk of Stroke in Type 2 Diabetes Estimated
by the UK Prospective Diabetes Study Risk Engine. Journal of the American
Heart Assosiation. 33:1778.
Kumar, V., Cotran, R.S., Robbins, S.T. 2007. Buku Ajar Patologi Volume 2.
Edisi 7. Jakarta:EGC pp. 367-377.
Lim, J.H., Lee, Y.S., Chang, H.C., Moon, M.K., Song, J.Y. 2011. Association
between Dietary Patterns and Blood Lipid Profiles in Korean Adults with
Type 2 Diabetes. J Korean Med Sci. 26:1201-1208.
McCance, K.L., Hyuther S.E. 2006. Pathophysiology The Biologic Basic For
Disease In Adult and Children Fifth Edition . Philadelphia:Elsevier Mostly pp
565&700.
Mumpuni, Y., Wulandari, A. 2011. Cara Jitu Mengatasi Kolesterol: Cerdas
Mengatasi dan Mengendalikan Kolesterol. Jakarta:Penerbit Andi pp 44.
Nathan, D.M. 2002. Initial Management Of Glycemia In Type 2 Diabetes
Mellitus. The New England Journal Medicine. 347:1343-1344.
Neal, M.J. 2007. At a Glance Farmakologi Medis. Jakarta:Erlangga Medical
Series p 47.
51
Nesto, R.W. 2008. LDL Cholesterol Lowering in Type Diabetes: What Is the
Optimum Approach?. Clinical Diabetes. 26:9.
NHLBI 2002. National Institutes of Health, Detection, Evaluation and Treatment
of High Blood Cholesterol in Adults (Adults Treatment Panel III). pp 23-24.
Ni, Khan., L, Naz., Mustaq., Rukh., Hussain. 2009. Ischemic Stroke: Prevalence
of Modifiable Risk Factor in Male and Female Patient in Pakistan. Pak. J.
Pharm. Sci. 22:62.
Notoadmodjo, S. 2005. Metodologi Penelitian Kesehatan. Jakarta: Rineka Cipta.
Park, Adrian. 2010. Hyperlipidaemia. Medical Progress. 37:382.
PERKENI 2006. Konsesus Pengelolahan dan Pencegahan Diabetes Melitus Tipe
2 di Indonesia.
Price, S.A., Wilson, L.M. 2006. Patofisiologi Konsep Klinis Proses-Proses
Penyakit Volume 2. Edisi 6. Jakarta:EGC pp. 1113.
Rasyid, A., Soertidewi, Lyna. 2007. Unit Stroke Manajemen Stroke Secara
Komprehensif. Jakarta: Balai Penerbti FKUI. pp 26.
RISKESDAS. 2007. Riset Kesehatan Dasar (Riskesdas) Laporan Provinsi Jawa
Tengah. Jakarta:Badan Penelitian dan Perkembangan Kesehatan.
Romero, J.R., Morris, J., Pikula, A. 2008. Stroke Prevention: Modifying Risk
Factors. Ther Adv Cardiovasc Dis. 2:291.
Sander, D., Sander, K., Poppert, H. 2008. Review: Stroke in Type 2 diabetes.
Journal of Diabetes and Vaskular Disease. 8:224.
Semenkovich, C.F. 2006. Insulin Resistance and Atherosclerosis. The Journal of
Clinical Investigation. 116:1813.
Setiawan, B., Suhartono, E. 2005. Stres Oksidatif dan Peran Antioksidan pada
Diabetes Melitus. Majalah Kedokteran Indonesia. 55:87.
Shao-Hua, W. 2009. Dyslipidaemia Among Diabetic Patients with Ischemic
Stroke in a Chinese Hospital. Chinese Medical Journal. 122:2569.
Silbernagl, S., Lang, F. 2007. Teks & Atlas Berwarna Patofisiologi. Jakarta:EGC
pp 246-247.
52
Simonen, P.P., Gylling, H., Miettinen, T. 2002. Diabetes Contributes to
Cholesterol Metabolism Regardless of Obesity. Diabetes Care. 25:151.
Soegondo, S., Pradana, S., Subekti, I. 2009. Penatalaksanaan Diabetes Melitus
Terpadu. Jakarta:Balai Penerbit FKUI pp 17-29.
Tjay, H.T., Rahardja, K. 2007. Obat-Obat Penting Khasiat, Penggunaan dan
Efek-Efek Sampingnya Edisi Keenam. Jakarta: Elex Media Komputindo p
580.
Underwood, J.C.E. 2000. Patologi Umum dan Sistemik Edisi 2 Volume 2 .
Jakarta:EGC. p 331.
WHO 2003. World Health Report 2003 Shaping the Future.
Worp, B.V.D., Ginjn, J.V. 2007. Acute Ischemic Stroke. The New England
Journal Medicine. 375:573.